West Pharmaceutical Services (NYSE:WST) Coverage Initiated by Analysts at Barclays
Barclays began coverage on shares of West Pharmaceutical Services (NYSE:WST – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat reports. The firm issued an equal weight rating and a $245.00 price objective on the medical instruments supplier’s stock. Several other equities analysts have also commented on the company. Evercore ISI […]
Barclays began coverage on shares of West Pharmaceutical Services (NYSE:WST – Free Report) in a research report sent to investors on Tuesday morning, Marketbeat reports. The firm issued an equal weight rating and a $245.00 price objective on the medical instruments supplier’s stock. Several other equities analysts have also commented on the company. Evercore ISI […]
